ICPT

{"sector":"","industry":"","symbol":"ICPT","company_name":"Intercept Pharmaceuticals, Inc...","exchange":"NASDAQ"}

ICPT Articles

These are the top analyst upgrades, downgrades, and initiations seen before markets opened on Friday, July 14, 2023.
Friday's top analyst upgrades and downgrades included Citizens Financial, Eaton, Freeport-McMoRan, General Mills, Graphic Packaging, Micron Technology, Mosaic, Netflix, Pfizer, Roku, Ross Stores and...
Tuesday's top analyst upgrades and downgrades included Altria, American International Group, Datadog, DraftKings, Emerson Electric, Marriott International, NortonLifeLock, Opendoor Technologies,...
Tuesday afternoon's top analyst upgrades and downgrades included Alcoa, American Tower, Las Vegas Sands, Paychex, US Steel and more.
Friday's top analyst upgrades and downgrades included Duke Energy, Macy's, Mosaic, Nvidia, SAP, ServiceNow, Shopify and Workday.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Nielsen, Nordstrom, PayPal, StoneCo and more.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Exxon, Kohl’s, MGM, Spotify and more.
Friday's top analyst upgrades and downgrades included Airbnb, Discovery, DoorDash, Hewlett Packard Enterprise, Intel, Snap and Spotify.
Monday's top analyst upgrades and downgrades included Ally Financial, Callaway Golf, Infinera, Lithia Motors, Microsoft, Nike, SolarWinds, Tapestry and Walmart.
Tuesday's top analyst upgrades and downgrades included AbbVie, Beyond Meat, Biogen, Eli Lilly, Levi Strauss, Nvidia, Pfizer, Plug Power, Raytheon, Square and Wayfair.
Tuesday's top analyst upgrades and downgrades included ANGI Homeservices, Carnival, Chegg, Clorox, Crocs, Dish Network, Etsy, Intercept Pharmaceuticals, Micron Technology, Okta, Seattle Genetics,...
Intercept Pharmaceuticals stock was crushed early on Monday after the firm received an update from the FDA in regards to its treatment of fibrosis due to nonalcoholoic steatohepatitis.
These five top biotech companies range from a large-cap leader with a potential coronavirus treatment to a small-cap company with massive upside potential.
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk...
Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch for in early 2020.